• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Strategy Announces Bond Purchases Instead of Bitcoin Accumulation

chest

Strategy, led by Michael Saylor, announced a temporary pause in Bitcoin purchases to buy bonds for debt management.

user avatarTando Nkube

Chainlink's Role in the Cryptocurrency Market

chest

Sam Daodu discusses Chainlink's undervaluation and its critical role in the crypto ecosystem.

user avatarKofi Adjeman

Bitcoin Supply in Profit Declines Amid Market Volatility

chest

The percentage of Bitcoin supply held in profit has dropped significantly, indicating a shift in market dynamics and investor sentiment.

user avatarNguyen Van Long

Jeff Park Draws Parallels Between Crypto and Early AI Development

chest

Jeff Park argues that the cryptocurrency industry is in a transitional phase similar to the early days of AI, where the potential is recognized by a few but not yet by the broader market.

user avatarSatoshi Nakamura

Crypto Analyst Defends Bitcoin's Four-Year Cycle Theory

chest

Crypto analyst Mags defends the validity of Bitcoin's four-year cycle theory, arguing it is still active despite claims from some experts that it has ended.

user avatarJesper Sørensen

XRP Faces Selling Pressure Below 140

chest

XRP struggles below the critical resistance level of 140 due to selling pressure and deteriorating liquidity conditions.

user avatarRajesh Kumar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.